Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,024 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology.
Virani SS, Aspry K, Dixon DL, Ferdinand KC, Heidenreich PA, Jackson EJ, Jacobson TA, McAlister JL, Neff DR, Gulati M, Ballantyne CM. Virani SS, et al. Among authors: ballantyne cm. Am J Prev Cardiol. 2023 Feb 27;13:100472. doi: 10.1016/j.ajpc.2023.100472. eCollection 2023 Mar. Am J Prev Cardiol. 2023. PMID: 36970638 Free PMC article. Review.
Maximizing the cost-effectiveness of lipid-lowering therapy.
Jacobson TA, Schein JR, Williamson A, Ballantyne CM. Jacobson TA, et al. Among authors: ballantyne cm. Arch Intern Med. 1998 Oct 12;158(18):1977-89. doi: 10.1001/archinte.158.18.1977. Arch Intern Med. 1998. PMID: 9778197 Review.
Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels.
Ballantyne CM, Andrews TC, Hsia JA, Kramer JH, Shear C; ACCESS Study Group. Atorvastatin Comparative Cholesterol Efficacy and Safety Study. Ballantyne CM, et al. Am J Cardiol. 2001 Aug 1;88(3):265-9. doi: 10.1016/s0002-9149(01)01638-1. Am J Cardiol. 2001. PMID: 11472705 Clinical Trial.
How to identify patients with vulnerable plaques.
Virani SS, Ballantyne CM. Virani SS, et al. Among authors: ballantyne cm. Diabetes Obes Metab. 2008 Sep;10(10):824-33. doi: 10.1111/j.1463-1326.2007.00812.x. Epub 2007 Oct 29. Diabetes Obes Metab. 2008. PMID: 17970757 Review.
Preoperative statin therapy decreases risk of postoperative renal insufficiency.
Virani SS, Nambi V, Polsani VR, Lee VV, Elayda M, Kohsaka S, Pan W, Reul RM, Wilson JM, Petersen LA, Willerson JT, Ballantyne CM. Virani SS, et al. Among authors: ballantyne cm. Cardiovasc Ther. 2010 Apr;28(2):80-6. doi: 10.1111/j.1755-5922.2009.00124.x. Cardiovasc Ther. 2010. PMID: 20398096 Free article.
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.
Virani SS, Nambi V, Hoogeveen R, Wasserman BA, Coresh J, Gonzalez F 2nd, Chambless LE, Mosley TH, Boerwinkle E, Ballantyne CM. Virani SS, et al. Among authors: ballantyne cm. Eur Heart J. 2011 Feb;32(4):459-68. doi: 10.1093/eurheartj/ehq367. Epub 2010 Oct 12. Eur Heart J. 2011. PMID: 20943669 Free PMC article.
1,024 results